Santen Pharmaceutical Co Ltd (4536.T)
4536.T on Tokyo Stock Exchange
1,844JPY
3:29am BST
1,844JPY
3:29am BST
Change (% chg)
¥25 (+1.37%)
¥25 (+1.37%)
Prev Close
¥1,819
¥1,819
Open
¥1,830
¥1,830
Day's High
¥1,854
¥1,854
Day's Low
¥1,830
¥1,830
Volume
355,900
355,900
Avg. Vol
1,178,944
1,178,944
52-wk High
¥1,946
¥1,946
52-wk Low
¥1,463
¥1,463
Revenue & Earnings Per Share
| Revenue* | Earnings Per Share** | ||
|---|---|---|---|
| FY 2018 | Dec | 57,817.00 | 29.598 |
| Sep | 54,826.00 | 15.300 | |
| Jun | 55,948.00 | 22.116 | |
| FY 2017 | Mar '17 | 48,429.00 | 7.966 |
| Dec | 52,838.00 | 17.640 | |
| Sep | 47,823.00 | 12.478 | |
| Jun | 50,006.00 | 17.613 | |
| FY 2016 | Mar '16 | 46,087.00 | 8.384 |
| Dec | 51,331.00 | 14.986 | |
| Sep | 49,898.00 | 86.897 | |
| Jun | 47,975.00 | 18.152 |
*Note: Units in Millions ofYen
**Note: Units in Yen
Consensus Estimates Analysis
| # of Estimates | Mean | High | Low | 1 Year Ago | |
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Sep-18 | 1 | 55,700.00 | 55,700.00 | 55,700.00 | -- |
| Quarter Ending Dec-18 | 1 | 59,400.00 | 59,400.00 | 59,400.00 | -- |
| Year Ending Mar-18 | 10 | 221,325.00 | 224,900.00 | 206,000.00 | 211,715.00 |
| Year Ending Mar-19 | 10 | 230,470.00 | 238,703.00 | 212,000.00 | 221,405.00 |
| Earnings (per share) | |||||
| Quarter Ending Sep-18 | 1 | 20.66 | 20.66 | 20.66 | -- |
| Quarter Ending Dec-18 | 1 | 21.89 | 21.89 | 21.89 | -- |
| Year Ending Mar-18 | 11 | 76.74 | 80.42 | 68.62 | 69.99 |
| Year Ending Mar-19 | 11 | 74.82 | 83.22 | 60.30 | 76.97 |
| LT Growth Rate (%) | 2 | 10.33 | 13.27 | 7.40 | -11.20 |
Sales and Profit Figures in Japanese Yen (JPY);
Valuation Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| P/E Ratio (TTM) | 28.99 | 30.95 | 32.74 | |
| P/E High - Last 5 Yrs. | 30.21 | 40.70 | 45.72 | |
| P/E Low - Last 5 Yrs. | 13.18 | 23.63 | 24.22 | |
| Beta | 0.58 | 0.89 | 0.88 | |
| Price to Sales (TTM) | 3.46 | 3.94 | 5.71 | |
| Price to Book (MRQ) | 2.73 | 4.80 | 5.37 | |
| Price to Tangible Book (MRQ) | 4.49 | 5.61 | 6.95 | |
| Price to Cash Flow (TTM) | 20.38 | 22.91 | 23.32 | |
| % Owned Institutions | -- | 1.21 | 2.17 | |
Dividends
| Company | industry | sector | ||
|---|---|---|---|---|
| Dividend Yield | 1.49 | 1.56 | 1.50 | |
| Dividend Yield - 5 Year Avg | 1.65 | 1.57 | 1.51 | |
| Dividend 5 Year Growth Rate | 5.39 | 4.47 | 5.32 | |
| Payout Ratio(TTM) | 43.17 | 45.35 | 43.29 | |
Growth Rates
| Company | industry | sector | ||
|---|---|---|---|---|
| Sales (MRQ) vs Qtr. 1 Yr. Ago | 11.88 | 3.69 | 9.21 | |
| Sales (TTM) vs TTM 1 Yr. Ago | 3.91 | 4.83 | 5.69 | |
| Sales - 5 Yr. Growth Rate | 11.72 | 10.08 | 10.32 | |
| EPS (MRQ) vs Qtr. 1 Yr. Ago | 24.23 | 16.36 | 19.36 | |
| EPS (TTM) vs TTM 1 Yr. Ago | -52.93 | -- | -- | |
| EPS - 5 Yr. Growth Rate | 7.31 | 9.87 | 10.76 | |
| Capital Spending - 5 Yr. Growth Rate | 23.70 | 15.52 | 15.47 | |
Financial Strength
| Company | industry | sector | |
|---|---|---|---|
| Quick Ratio (MRQ) | 2.62 | 2.12 | 2.19 |
| Current Ratio (MRQ) | 3.16 | 2.90 | 2.98 |
| LT Debt to Equity (MRQ) | 2.37 | 9.88 | 12.18 |
| Total Debt to Equity (MRQ) | 8.05 | 13.86 | 16.45 |
| Interest Coverage (TTM) | 47.31 | 35.89 | 32.81 |
Profitability Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| Gross Margin (TTM) | 61.88 | 54.81 | 54.44 | |
| Gross Margin - 5 Yr. Avg. | 63.12 | 52.15 | 52.20 | |
| EBITD Margin (TTM) | 21.40 | -- | -- | |
| EBITD - 5 Yr. Avg | 28.55 | 18.57 | 10.96 | |
| Operating Margin (TTM) | 16.45 | 14.36 | 4.73 | |
| Operating Margin - 5 Yr. Avg. | 24.66 | 14.52 | 6.40 | |
| Pre-Tax Margin (TTM) | 16.47 | 14.82 | 5.57 | |
| Pre-Tax Margin - 5 Yr. Avg. | 24.72 | 14.90 | 6.81 | |
| Net Profit Margin (TTM) | 12.02 | 11.07 | 1.87 | |
| Net Profit Margin - 5 Yr. Avg. | 16.64 | 11.20 | 3.09 | |
| Effective Tax Rate (TTM) | 27.04 | 23.16 | 23.04 | |
| Effective Tax Rate - 5 Yr. Avg. | 32.70 | 23.42 | 23.96 | |
Efficiency
| Company | industry | sector | ||
|---|---|---|---|---|
| Revenue/Employee (TTM) | 55,914,640 | 938,079,907 | 846,829,796 | |
| Net Income/Employee (TTM) | 6,721,026 | 110,368,362 | 99,616,056 | |
| Receivable Turnover (TTM) | 2.81 | 5.63 | 5.78 | |
| Inventory Turnover (TTM) | 2.98 | 2.59 | 3.35 | |
| Asset Turnover (TTM) | 0.63 | 0.95 | 0.92 | |
Management Effectiveness
| Company | industry | sector | ||
|---|---|---|---|---|
| Return on Assets (TTM) | 7.53 | 11.40 | 10.95 | |
| Return on Assets - 5 Yr. Avg. | 10.07 | 12.91 | 12.31 | |
| Return on Investment (TTM) | 8.89 | 14.84 | 14.38 | |
| Return on Investment - 5 Yr. Avg. | 12.19 | 16.88 | 16.10 | |
| Return on Equity (TTM) | 9.56 | 16.34 | 16.07 | |
| Return on Equity - 5 Yr. Avg. | 13.23 | 17.98 | 17.39 | |
| 1 Year | 3 Year | 5 Year | |
|---|---|---|---|
| Sales % | 1.95 | 10.83 | 11.72 |
| EPS (TTM) % | -56.40 | 5.54 | 7.31 |
| Dividend % | 4.00 | 9.14 | 5.39 |
Note: Units in Millions of US Dollars
Performance for Santen Pharmaceutical Co Ltd
| Period | % Actual |
% vs. S&P 500 |
Rank In Industry |
Industry Rank |
|---|---|---|---|---|
| 4 Week | -2.24 | -7.67 | 99 | 23 |
| 13 Week | 13.02 | 7.65 | 99 | 34 |
| 26 Week | 15.03 | 1.57 | 99 | 29 |
| 52 Week | 14.80 | -7.87 | 99 | 12 |
| YTD | 22.03 | 9.84 | 99 | 25 |
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.
Institutional Holders
| % Shares Owned: | 45.36% |
| # of Holders: | 225 |
| Total Shares Held: | 184,542,098 |
| 3 Mo. Net Change: | 17,842,404 |
| # New Positions: | 2 |
| # Closed Positions: | 3 |
| # Increased Positions: | 53 |
| # Reduced Positions: | 38 |
| # Net Buyers: | 15 |
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.